Over the past five years, the FCSC has invested $3.5 million in replacing or updating its instruments, expanding capacity, and developing new services such as multiplex immunofluorescence, Hanumanthu ...
Combines BioSkyrb’ s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384- well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, ...
DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb Genomics, a company ushering in the next generation of single-cell technology, today announced the commercial launch of its new ResolveDNA Whole Genome and ...
Flow core facilities are under growing pressure to support fragile cells, rare populations, and advanced applications such as single-cell multiomics and cell therapy workflows, all while meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results